ScreenPoint Medical today announced that its Transpara® breast imaging AI solution has been selected as the technology of choice for the PRISM (Pragmatic Randomized Trial of Artificial Intelligence ...
IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated and full approval – – KOMET-017-NIC trial of ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has asked ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
News-Medical.Net on MSN
Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...
Kura Oncology (KURA) and Kyowa Kirin Co. announced that the first patient has been dosed under the KOMET-017 clinical trial protocol ...
Can AI not just analyze human behavior, but interact with it, shape it, and outperform people at tasks we thought only humans ...
Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...
Noting the results of the Phase II trial for the Inactivated Chikungunya vaccine, the Subject Expert Committee (SEC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback